1. Alexandrescu D, Fabi S, Yeh LC, et al., 2016. Comparative results in treatment of keloids with intralesional 5-FU/kenalog, 5-FU/verapamil, enalapril alone, verapamil alone, and laser: a case report and review of the literature. J Drugs Dermatol, 15(11):1442–1447.
2. Arno AI, Amini-Nik S, Blit PH, et al., 2014. Effect of human Wharton’s jelly mesenchymal stem cell paracrine signaling on keloid fibroblasts. Stem Cells Transl Med, 3(3):299–307. https://doi.org/10.5966/sctm.2013-0120
3. Balestri R, Misciali C, Zampatti C, et al., 2013. Keloidal basal cell carcinoma: should it be considered a distinct entity? J Dtsch Dermatol Ges, 11(12):1196–1198. https://doi.org/10.1111/ddg.12168
4. Berman B, Perez OA, Konda S, et al., 2007. A review of the biologic effects, clinical efficacy, and safety of silicone elastomer sheeting for hypertrophic and keloid scar treatment and management. Dermatol Surg, 33(11):1291–1303. https://doi.org/10.1111/j.1524-4725.2007.33280.x
5. Bloemen MCT, van der Veer WM, Ulrich MMW, et al., 2009. Prevention and curative management of hypertrophic scar formation. Burns, 35(4):463–475. https://doi.org/10.1016/j.burns.2008.07.016